|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.7 GBX | -2.92% |
|
-4.66% | -15.69% |
| 21/06 | European IPOs fizzle out as political turmoil roils stocks | RE |
| 20/06 | UBS raises Landsec; Berenberg cuts SSP | AN |
Dr. Martens plc reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was GBP 877.1 million compared to GBP 1,000.3 million a year ago. Net income was GBP 69.2 million compared to GBP 128.9 million a year ago.
Basic earnings per share from continuing operations was GBP 0.07 compared to GBP 0.129 a year ago. Diluted earnings per share from continuing operations was GBP 0.07 compared to GBP 0.129 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.69% | 908M | |
| +44.81% | 24.63B | |
| +10.88% | 10.54B | |
| +11.66% | 10.22B | |
| +15.60% | 9.77B | |
| +56.24% | 8.86B | |
| -15.14% | 6.88B | |
| +13.27% | 3.17B | |
| +74.77% | 3.12B | |
| 0.00% | 2.53B |
DR. MARTENS PLC 
